Active Clinical Trials, No Longer Recruiting

When last investigated, it was being reported that the following trials were active but no longer recruiting participants. When completed, these trials may provide helpful information for mesothelioma treatment.

Pemetrexed Disodium and Gemcitabine in Treating Patients with Malignant Mesothelioma Condition: Mesothelioma

Vaccine Therapy and Ganciclovir in Treating Patients with Mesothelioma
Condition: Mesothelioma

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients with Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen Condition: Mesothelioma

Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients with Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients with Malignant Pleural Mesothelioma
Condition: Mesothelioma

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients with Malignant Pleural Mesothelioma
Condition: Mesothelioma

Pazopanib in Treating Patients with Malignant Pleural Mesothelioma
Condition: Mesothelioma

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients with Peritoneal Cancer
Condition: Mesothelioma

Interleukin-12 in Treating Patients with Cancer in the Abdomen
Conditions: Mesothelioma, Anal or Colorectal Cancer, Carcinoma of the Appendix, Cancer involving the Bile Duct or Gallbladder, Pancreatic Cancer, Gastric Cancer or Gastrointestinal Carcinoid Tumor, Small Intestine Cancer

High-Dose Megestrol in Treating Patients with Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Conditions: Mesothelioma, Breast or Endometrial Cancer

AZD2171 in Treating Patients with Malignant Pleural Mesothelioma that Cannot Be Removed by Surgery
Condition: Mesothelioma

Alanosine in Treating Patients with Cancer
Conditions: Lung Cancer; Malignant Mesothelioma; Pancreatic Cancer; Sarcoma

Combination Chemotherapy with or without Surgery and Chemoradiotherapy in Treating Patients with Malignant Pleural Mesothelioma
Condition: Mesothelioma

Active Symptom Control with or without Chemotherapy in Treating Patients with Malignant Pleural Mesothelioma
Condition: Mesothelioma

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Condition: Mesothelioma

Combination Chemotherapy Before Surgery in Treating Patients with Mesothelioma of the Lung
Condition: Mesothelioma

Vaccine Therapy in Treating Patients with Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer or with Stage I or Stage II Mesothelioma
Conditions: Lung Cancer; Mesothelioma

Cyclophosphamide Plus Vaccine Therapy in Treating Patients with Advanced Cancer Conditions: Breast Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Kidney Cancer, Mesothelioma

Radiofrequency Ablation in Treating Patients with Refractory or Advanced Lung Cancer Conditions: Lung Cancer, Mesothelioma, Thymoma and Thymic Carcinoma, Metastatic Cancer

Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients with Pleural Mesothelioma
Condition: Mesothelioma

Intrapleural BG00001 in Treating Patients with Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Condition: Cancer

Extrapleural Pneumonectomy with Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin with Amifostine and Sodium Thiosulfate
Conditions: Pleural Mesothelioma